Mesalamine Tablet, Delayed Release
Product Images NDC 60687-397

4 FDA label images from American Health Packaging · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 60687-397). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Ahp39725

Ahp39725
Mesalamine 1.2 g delayed-release tablets, oral dosage form, shown in brown, oval-shaped tablets with the imprint "711" on one side. The image displays both front and back views of the tablets. Labeler: American Health Packaging.*
FDA Label Image

Blister

Blister
The image shows a label for Mesalamine 1.2 g delayed-release tablets, USP for oral use. The label indicates once daily dosing and includes lot number 123456 and expiry date 03/21. It is manufactured by American Health Packaging, Columbus, OH 43217, with Product NDC 60687-397. The label is repeated three times, intended for tablet bottles.*
FDA Label Image

Carton

Carton
Mesalamine 1.2 g delayed-release tablets label by American Health Packaging. The label states the dosage strength as 1.2 g and package quantity as 30 tablets. It includes instructions for storage, dosage reference, safety warnings, and distributor information for American Health Packaging, Columbus, Ohio. The label features the NDC 60687-397-25 and barcode graphics.*
FDA Label Image

Structure

Structure
Chemical structure of Mesalamine showing a benzene ring with amino, hydroxyl, and carboxyl functional groups attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.